$7.13
1.79% yesterday
Nasdaq, Oct 17, 10:01 pm CET
ISIN
US2290503075
Symbol
CYRX

CryoPort Stock price

$7.13
-1.26 15.02% 1M
-9.66 57.53% 6M
-8.36 53.97% YTD
-5.44 43.28% 1Y
-63.89 89.96% 3Y
-7.89 52.53% 5Y
+2.57 56.36% 10Y
Nasdaq, Closing price Thu, Oct 17 2024
-0.13 1.79%
ISIN
US2290503075
Symbol
CYRX
Industry

Key metrics

Market capitalization $352.31m
Enterprise Value $360.05m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.60
P/S ratio (TTM) P/S ratio 1.56
P/B ratio (TTM) P/B ratio 0.95
Revenue growth (TTM) Revenue growth -6.26%
Revenue (TTM) Revenue $225.61m
EBIT (operating result TTM) EBIT $-72.01m
Free Cash Flow (TTM) Free Cash Flow $-36.57m
Cash position $427.14m
EPS (TTM) EPS $-3.67
P/E forward negative
P/S forward 1.52
EV/Sales forward 1.56
Short interest 6.41%
Show more

Is CryoPort a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,907 stocks worldwide.

CryoPort Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a CryoPort forecast:

4x Buy
40%
6x Hold
60%

Analyst Opinions

10 Analysts have issued a CryoPort forecast:

Buy
40%
Hold
60%

Financial data from CryoPort

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
226 226
6% 6%
100%
- Direct Costs 148 148
2% 2%
66%
77 77
14% 14%
34%
- Selling and Administrative Expenses 101 101
14% 14%
45%
- Research and Development Expense 19 19
15% 15%
9%
-43 -43
180% 180%
-19%
- Depreciation and Amortization 29 29
17% 17%
13%
EBIT (Operating Income) EBIT -72 -72
79% 79%
-32%
Net Profit -173 -173
346% 346%
-76%

In millions USD.

Don't miss a Thing! We will send you all news about CryoPort directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CryoPort Stock News

Neutral
PRNewsWire
3 days ago
Partnership Will Enhance Support for Biopharmaceutical Companies in Developing Cell and Gene Therapies and mRNA-Based Treatments NASHVILLE, Tenn. and CONROE, Texas , Oct. 15, 2024 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for the life sciences, and VGXI, Inc., (VXGI) a subsidiary of GeneOne Life Science Inc. ("GeneOne" KOSPI: 011000) t...
Neutral
PRNewsWire
11 days ago
The IntegriCell Platform Will Deliver High-Quality Cryopreservation Services for Cell-Based Therapies NASHVILLE, Tenn. , Oct. 7, 2024 /PRNewswire/ -- Cryoport, Inc.  (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in supply chain solutions for the life sciences, today announced the launch of its IntegriCell™ cryopreservation services solution provided by Cryoport Systems with the ...
Neutral
PRNewsWire
23 days ago
NASHVILLE, Tenn. and RANCHO CORDOVA, Calif.
More CryoPort News

Company Profile

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.

Head office United States
CEO Jerrell Shelton
Employees 1,170
Founded 1990
Website www.cryoport.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today